Elicit
Day 32 after signup
Five sources Elicit’s Research Agent uses beyond research papers
Why it works
- Open with a specific research question to show why the topic matters before explaining the sources.
- Give each source a concise description of what it contributes, then make the next step clear with one prominent article link.
How it is built
- Casual greeting
- Article introduction
- Research question example
- Five source summaries
Email copy
Hey there, We just published a new blog post on the sources Elicit’s Research Agent can draw on beyond research papers. Take a question like: is TREM2 a promising target for Alzheimer’s disease? Papers tell you part of the story, but the human genetic evidence is in Open Targets, the competitive landscape is in patent filings, and potency data is in ChEMBL. Answering well means finding each piece and putting it all together. The post covers five of those sources, what each one adds, and the kinds of questions that trigger it: Patents: who owns a composition or method, and how broad their claims are Target–disease evidence: structured genetic and clinical support linking genes to diseases Cancer dependencies: whether a gene is a selective vulnerability or something every cell needs Safety reports: what’s been reported for marketed drugs and devices, and whether a signal is growing Drug chemistry: standardized potency measurements like IC50, Ki, and Kd Read the full post here: Where Elicit looks beyond research papers Happy reading, Shahid Growth, Elicit Help Center Elicit Tutorials You are receiving this email because you signed up for Elicit, an AI research assistant. You can manage email preferences here. View this email online here.